• Return to Headlines

Watch for Continued Gains in Shares of Dexcom (DXCM)

By James Quinn

Dexcom (NASDAQ:DXCM) traded at a new 52-week high today of $158.77. So far today approximately 136,000 shares have been exchanged, as compared to an average 30-day volume of 839,000 shares.

Dexcom (NASDAQ:DXCM) is currently priced 48.8% above its average consensus analyst price target of $81.25. Dexcom shares have support at the 50-day moving average (MA) of $141.14 and additional support at the 200-day MA of $133.23.

In the past 52 weeks, Dexcom share prices have been bracketed by a low of $85.76 and a high of $158.77 and are now at $158.77, 85% above that low price. The 200-day and 50-day moving averages have moved 0.38% higher and 1.51% higher over the past week, respectively.

DexCom Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The Company has developed a small implantable device that continuously measures glucose levels in subcutaneous tissue just under the skin, and a small external receiver to which the sensor transmits glucose levels at specified intervals.

SmarTrend is monitoring the recent change of momentum in Dexcom. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Dexcom in search of a potential trend change.

Keywords: 52 week high/lows dexcom

Ticker(s): DXCM